CannaPharmaRX files payment schedules with debtholders in SEC filing

Published 10/10/2025, 17:04
CannaPharmaRX files payment schedules with debtholders in SEC filing

CannaPharmaRX, Inc. (OTC:CPMD) reported that it has entered into letter agreements outlining payment schedules to address outstanding amounts due to two significant debtholders. The company disclosed these actions in a filing with the Securities and Exchange Commission.

According to the statement, CannaPharmaRX developed the payment schedules as a means to manage its existing debts and avoid further defaults, while retaining capital to continue operations and product delivery. The company noted that information about the payment schedules was previously included in its quarterly report for the period ending June 30, 2025, but the actual agreements were not attached at that time due to an oversight.

The company is now filing the payment schedule agreements as exhibits to its current report. The repayment schedules relate to amounts owed to A. Tal and Koze Investments, as listed in the filing.

CannaPharmaRX is incorporated in Delaware and is based in Calgary, Alberta, Canada. Its common stock is traded on the OTC Markets under the symbol CPMD.

This information is based on a statement made in a press release and the company’s SEC filing.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.